Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expression

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Yee, Jade ^a   White, Robert E ^a   Anderton, Emma ^a,b   Allday, Martin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; EPSTEIN BARR VIRUS ANTIGEN 3A; EPSTEIN BARR VIRUS ANTIGEN 3B; EPSTEIN BARR VIRUS ANTIGEN 3C; ETOPOSIDE; IONOMYCIN; PROTEIN EBER; PROTEIN LMP; PROTEIN NOXA; PROTEIN P53; SHORT HAIRPIN RNA; STAUROSPORINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; MESSENGER RNA; PMAIP1 PROTEIN, HUMAN; PROTEIN BCL 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; NONHUMAN; OPEN READING FRAME; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS GENE; WESTERN BLOTTING; ANTIVIRAL RESISTANCE; B LYMPHOCYTE; CELL LINE; DRUG EFFECT; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY; VIROLOGY; VIRUS LATENCY;

APOPTOSIS; B-LYMPHOCYTES; CELL LINE; DRUG RESISTANCE, VIRAL; ETOPOSIDE; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKOUT TECHNIQUES; GENETIC LOCI; HERPESVIRUS 4, HUMAN; HUMANS; IONOMYCIN; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAUROSPORINE; VIRAL PROTEINS; VIRUS LATENCY;

EID: 83055182225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028506     Document Type: Article

References (47)

1. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
2. Bornkamm GW, Hammerschmidt W, (2001) Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 437-459.
3. Thorley-Lawson DA, Gross A, (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337.
4. Thorley-Lawson DA, Allday MJ, (2008) The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6: 913-924.
5. Roughan JE, Thorley-Lawson DA, (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol.
6. Crawford DH, (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 461-473.
7. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA, (1999) Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190: 567-576.
8. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, et al. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90: 8479-8483.
9. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM, (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267: 24157-24160.
10. Kennedy G, Komano J, Sugden B, (2003) Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A 100: 14269-14274.
11. Lee JM, Lee KH, Weidner M, Osborne BA, Hayward SD, (2002) Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis. Proc Natl Acad Sci U S A 99: 11878-11883.
12. Wang S, Rowe M, Lundgren E, (1996) Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 56: 4610-4613.
13. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, et al. (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612-614.
14. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, et al. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115.
15. Garibal J, Hollville E, Bell AI, Kelly GL, Renouf B, et al. (2007) Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A. J Virol 81: 7598-7607.
16. Altmann M, Hammerschmidt W, (2005) Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3: e404.
17. Defrance T, Casamayor-Palleja M, Krammer PH, (2002) The life and death of a B cell. Adv Cancer Res 86: 195-225.
18. Allday MJ, (2009) How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? Semin Cancer Biol 19: 366-376.
19. Kelly GL, Rickinson AB, (2007) Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology Am Soc Hematol Educ Program pp. 277-284.
20. Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, et al. (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,-3B, and-3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79: 10709-10717.
21. Leao M, Anderton E, Wade M, Meekings K, Allday MJ, (2007) Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. J Virol 81: 248-260.
22. Anderton E, Yee J, Smith P, Crook T, White RE, et al. (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27: 421-433.
23. Allday MJ, Sinclair A, Parker G, Crawford DH, Farrell PJ, (1995) Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. Embo J 14: 1382-1391.
24. O'Nions J, Turner A, Craig R, Allday MJ, (2006) Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53. J Virol 80: 12408-12413.
25. Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, et al. (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5: e1000341.
26. Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T, (1991) p53 is frequently mutated in Burkitt's lymphoma cell lines. Embo J 10: 2879-2887.
27. Speck SH, (2002) EBV framed in Burkitt lymphoma. Nat Med 8: 1086-1087.
28. Kelly G, Bell A, Rickinson A, (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8: 1098-1104.
29. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, et al. (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 183: 1957-1964.
30. O'Nions J, Allday MJ, (2004) Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J Gen Virol 85: 881-895.
31. White RE, Groves IJ, Turro E, Yee J, Kremmer E, et al. (2010) Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS One 5: e13979.
32. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, et al. (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160: 151-161.
33. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, et al. (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6.
34. Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, et al. (2011) A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7: e1001294.
35. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
36. Lindstrom MS, Wiman KG, (2002) Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 12: 381-387.
37. Tafani M, Minchenko DA, Serroni A, Farber JL, (2001) Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res 61: 2459-2466.
38. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL, (2002) The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 277: 16547-16552.
39. Strasser A, (2005) The role of BH3-only proteins in the immune system. Nat Rev Immunol 5: 189-200.
40. Skalsky RL, Cullen BR, (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64: 123-141.
41. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
42. White RE, Calderwood MA, Whitehouse A, (2003) Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J Gen Virol 84: 3393-3403.
43. Neuhierl B, Feederle R, Hammerschmidt W, Delecluse HJ, (2002) Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99: 15036-15041.
44. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ, (2001) Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J Virol 75: 7749-7755.
45. Finke J, Rowe M, Kallin B, Ernberg I, Rosen A, et al. (1987) Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J Virol 61: 3870-3878.
46. Inman GJ, Binne UK, Parker GA, Farrell PJ, Allday MJ, (2001) Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol 75: 2400-2410.
47. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, et al. (1991) An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5: 147-156.